NLS Pharmaceutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.

About NLSP

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness (EDS) and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder (ADHD). 

CEO
Alexander Zwyer
CEOAlexander Zwyer
Employees
6
Employees6
Headquarters
Zurich, Zurich
HeadquartersZurich, Zurich
Founded
2015
Founded2015
Employees
6
Employees6

NLSP Key Statistics

Market cap
13.07M
Market cap13.07M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
474.95K
Average volume474.95K
High today
$0.728
High today$0.728
Low today
$0.66
Low today$0.66
Open price
$0.66
Open price$0.66
Volume
321.96K
Volume321.96K
52 Week high
$2.83
52 Week high$2.83
52 Week low
$0.33
52 Week low$0.33

NLSP Earnings

Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Estimated per share
Actual
Expected Feb 25, Pre-Market
ActualExpected Feb 25, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.